x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Author: MarksMan Healthcare

    Marksman Healthcare > Articles by: MarksMan Healthcare

28May

Federated Data Networks (FDNs): Enhancing the Quality of RWE Research

by MarksMan Healthcare,  0 Comments

Real-World Data (RWD), from which Real-World Evidence (RWE) is generated, has the unique capability of depicting real-world outcomes. RWD can also reduce timelines for research and development, and generate profound […]

Read More

25May

How to Improve Transparency with Real World Data to Support Market Access?

by MarksMan Healthcare,  0 Comments

The USFDA defines real-world data (RWD) as ‘the data relating to patient health status and/or the healthcare delivery that is routinely collected from a variety of sources’, and real-world evidence […]

Read More

23May

Unlocking the Power of RWE: Changing Scenario in the Global Landscape

by MarksMan Healthcare,  0 Comments

There has been a shift in the global healthcare ecosystem from volume-based to value-based payment model, thanks to a surge in data availability, interoperability, advancing health technologies, cost and competitive […]

Read More

06May

The Role of Real World Evidence in Optimizing the Conduct of Clinical Trials

by MarksMan Healthcare,  0 Comments

Real-world evidence (RWE) is derived from real-world data (RWD) sources, such as electronic health records (EHRs), claims data, data from product/disease registries, pharmacy data, social media, and pragmatic trials. RWE […]

Read More

27Apr

How to Prepare Real World Evidence for Regulatory Approval?

by MarksMan Healthcare,  0 Comments

Drug makers usually put in rigorous efforts to fast-track and reduce the cost burden of regulatory decision-making by regulatory authorities like USFDA and EMA. As a part of these efforts, […]

Read More

21Apr

The Importance of Communicating the Value of Real World Evidence to Stakeholders

by MarksMan Healthcare,  0 Comments

Real-world evidence (RWE) has been used extensively for satisfying post-launch regulatory requirements, mainly about drug safety. Of late, it has been realized that RWE has a wide range of applications […]

Read More

13Apr

Big Data in Medicine and Artificial Intelligence: A Real World Challenge?

by MarksMan Healthcare,  0 Comments

Artificial Intelligence (AI) refers to a computerized system that performs physical tasks, cognitive functions, solves problems, and/ or makes decisions without overt human instructions.[1] First proposed by McCarthy in 1955, […]

Read More

08Apr

An Overview of Registry Studies and Considerations for Regulators

by MarksMan Healthcare,  0 Comments

A patient registry has been defined as “an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined […]

Read More

25Mar

Expanded Access Programme: an Important Initiative to Enhance Patient Access

by MarksMan Healthcare,  0 Comments

Patients with serious, life-threatening health conditions and who have no available treatment alternatives, often want to know if and how they can receive early access to investigational products, sometimes even […]

Read More

Posts navigation

1 2 3 4 5 … 14

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

May 15, 2023

Risk of Bias Assessment During Systematic Literature Reviews: Why and How?

May 8, 2023

Using ‘Limits’ While Developing SLR Search Strategy: Advantages and Disadvantages

April 13, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

May 15, 2023

Risk of Bias Assessment During Systematic Literature Reviews: Why and How?

May 8, 2023

Using ‘Limits’ While Developing SLR Search Strategy: Advantages and Disadvantages

April 13, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...